Close Menu

Health Sciences In The Media

  • Skipping radiation and receiving less chemotherapy may become the new standard of care for some lymphoma patients, according to a recent collaborative study led by a Daniel Persky, MD, associate director for clinical investigations at the UArizona Cancer Center.

  • Doctors are saying that the president is doing extremely well after being hospitalized with COVID-19 over the weekend. Dr. Shad Marvasti, of the University of Arizona College of Medicine – Phoenix, on what we are hearing about the president’s condition. Air time: 10:19 PM

  • The University of Arizona is launching a $7.7 million yearlong study funded by the U.S. Centers for Disease Control and Prevention to identify patterns of COVID-19 immunity over time in previously and newly infected individuals. Dr. Jeff Burgess, associate dean for research and a professor at the Mel and Enid Zuckerman College of Public Health, is serving as principal investigator for the study, named the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance, or AZ HEROES, Study.

  • HuffPost (UK) - Oct. 6

    Part of the virus that causes the illness Covid-19 could be used to help relieve pain, a new study suggests, by blocking the body’s pain pathway at a cellular level. Rajesh Khanna, a professor in the College of Medicine at the University of Arizona Health Sciences, and his research team found that the SARS-CoV-2 spike protein binds to neuropilin in exactly the same location as VEGF-A.

  • Scientists at the University of Arizona Health Sciences say the virus that causes COVID-19 may have a surprising ability to relieve pain. Laboratory experiments with rodents show when the virus enters the body by binding to a gateway protein called neuropilin, it blocks the first step in the pathway that causes pain. That might explain why so many people diagnosed with COVID-19 don’t feel any symptoms. KNAU spoke with the study’s senior author Dr. Rajesh Khanna from the UArizona College of Medicine, about his findings.

  • A new study from scientists at the University of Arizona Health Sciences center shows that the novel coronavirus has a second receptor that is linked to pain signaling.

  • Cronkite News - Oct. 5

    Colorectal cancer is the second-leading cause of cancer death among Native Americans, prompting calls for increased screenings to improve detection and treatment of colorectal disease. The University of Arizona Cancer Center is working to address this problem. The program was recently awarded $3 million by the National Cancer Institute’s Cancer Moonshot Initiative, which aims to accelerate cancer research and prevention.

  • In a small preliminary study, researchers affiliated with the University of Arizona Health Sciences Comprehensive Pain and Addiction Center exposed 29 people—all of whom experience episodic or chronic migraine and failed multiple traditional therapies, such as oral medications and Botox injections— to white and green light.

  • AZ Big Media - Oct. 4

    Q&A with Environmental microbiologists and public health researchers at the University of Arizona: Kelly Reynolds, professor and chair of the Community, Environment and Policy Department at the Mel and Enid Zuckerman College of Public Health and Charles Gerba, an environmental microbiologist from the College of Agriculture and Life Sciences.

  • Payson now has a state-of-the-art, high-tech telemedicine clinic, with the opening of the University of Arizona College of Medicine – Phoenix Rural Health Clinic. The clinic will train medical students and also offer treatment for everyone regardless of medical insurance status, taking advantage of the latest technology to run tests, talk to specialists and manage the care of complex medical issues.

  • Joe Gerald, a researcher at the University of Arizona Mel and Enid Zuckerman College of Public Health who tracks the coronavirus in Arizona, said it is too early to detect spread from campus outbreaks in the state, but it may be that the overlap between students and locals is minimal enough to prevent that.

  • ScienceDaily - Oct. 1

    SARS-CoV-2, the virus that causes COVID-19, can relieve pain, according to a new study by University of Arizona Health Sciences researchers. The finding may explain why nearly half of people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease, according to the study's senior author Rajesh Khanna, PhD, a professor in the College of Medicine -- Tucson's Department of Pharmacology.

  • Dr. Lisa Grimaldi, an associate professor in the Division of Cardiovascular ICU at the University of Arizona College of Medicine Phoenix, said most children who have tested positive for COVID-19 do not have symptoms or have only a very mild disease. Grimaldi also is pediatric critical care physician at Phoenix Children’s Hospital. She said there are reports out of New York and Europe that children are being hospitalized with a new disease that appears to be tied to Coronavirus. Called multisystem inflammatory syndrome in children (MIS-C).

  • The causes of cerebral palsy have long been debated and often are attributed to in utero infections, premature birth, or brain injury to the baby near or during delivery, usually from a lack of oxygen. But many young children diagnosed with cerebral palsy have not experienced such events. New research, the largest genetic study of cerebral palsy, supports previous findings and provides "the strongest evidence to date that a significant portion of cerebral palsy cases can be linked to rare genetic mutations, and in doing so identified several key genetic pathways involved," said co-senior author Dr. Michael Kruer, a neurogeneticist at Phoenix Children's Hospital and the University of Arizona College of Medicine.

  • Miami Herald - Sep. 30

    Concerns over the spread of the coronavirus as the U.S. enters its ninth month of the pandemic has prompted one city to ban Halloween trick-or-treating. Leila Barraza, an associate professor at University of Arizona in the College of Public Health and a Senior Consultant at the Network for Public Health Law says that recommendations, not outright bans, is likely the preferred approach by health officials. “There is always a balance of constitutional protections and potential for infringement on an individuals’ right versus protection of a community, just like with isolation and quarantine or vaccination laws,” she told McClatchy News. “That’s what some of these local jurisdictions are trying to do by giving these recommendations — giving people safer, lower risk options to follow.”

  • Drug Topics - Sep. 30

    Members of the MJH Life Sciences COVID-19 Coalition weighed in on the latest pandemic information in a recent survey. Saskia Popescu, an infectious disease epidemiologist and adjunct professor at the University of Arizona Mel and Enid Zuckerman College of Public Health, is one of the 10 coalition experts.

  • Payson Roundup - Sep. 29

    September is National Suicide Prevention Awareness Month — a time to share resources and stories that shed light on a stigmatized topic. In Gila County alone, veterans are nearly twice as likely than the general population to die by suicide. In an effort to prevent suicide and support veterans, their families and the community at large, the University of Arizona’s Center for Rural Health partnered with the Arizona Coalition for Military Families to expand the Be Connected veteran support program in rural southern Arizona counties, including Gila.

  • Ben Conner, a third-year MD/PhD student at the University of Arizona College of Medicine – Phoenix, is studying a robotic walking therapy for children with cerebral palsy.

  • Interview with Dr. Murtaza Akhter, an emergency physician at Valleywise Health Medical Center and assistant professor at the University of Arizona College of Medicine in Phoenix. 

  • University of Arizona College of Nursing Assistant Professor Jessica Rainbow and Chloe Littzen, a nursing PhD candidate, are seeking ways to mitigate nurse burnout which has intensified during the coronavirus pandemic. They are conducting research that will describe the experiences of frontline nurses prior to, and during, the COVID-19 pandemic.